Art
J-GLOBAL ID:200902282283912555   Reference number:04A0870560

Infectious Risks Associated with the Transfusion of Blood Components and Pathogen Inactivation in Japan

日本における血液成分の輸血に伴う感染リスクと病原体不活性化
Author (1):
Material:
Volume: 80  Issue:Page: 306-310  Publication year: Nov. 15, 2004 
JST Material Number: F0888A  ISSN: 0925-5710  CODEN: IJHEEY  Document type: Article
Article type: 解説  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0870560&from=J-GLOBAL&jstjournalNo=F0888A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of immunotherapeutic agents and blood preparations  ,  Physiology and pathogenicity of virus infection 
Reference (17):
  • OTAKE, K. Nucleic acid amplification testing of hepatitis B virus. Lancet. 2000, 355, 1460
  • MINE, H. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods. 2003, 112, 145-151
  • AUBUCHON, JP. Pathogen inactivation in cellular blood components : clinical trials and implications of introduction to transfusion medicine. Vox Sang. 2002, 83, suppl 1, 271-275
  • MCCULLOUGH, J. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation : the SPRINT trial. Blood. 2004, 104, 1534-1541
  • ATANCE, R. Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion. 2001, 41, 1548-1552
more...
Terms in the title (6):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page